The Journal of Immunoassay & Immunochemistry is an international forum for rapid dissemination of research results and methodologies dealing with all aspects of immunoassay and immunochemistry, as well as selected aspects of immunology. They include receptor assay, enzyme-linked immunosorbent assay (ELISA) in all of its embodiments, ligand-based assays, biological markers of ligand-receptor interaction, in vivo and in vitro diagnostic reagents and techniques, molecular analyses, point-of-care testing, clinical immunology and biomarkers in clinical trails, antibody isolation and purification, diagnosis of AIDS and SARS-CoV-2, vaccines and immunotherapies for COVID-19, among other topics.
Readership of the Journal includes immunochemists, clinical immunologists, molecular biologists, clinical chemists, clinical diagnosticians, toxicologists, forensic scientists, allergists, pathologists, oncologists, epidemiologists, and infectious disease clinicians and scientists.
Peer Review Policy All submitted manuscripts are subject to initial appraisal by the Editor-in-Chief, and, if found suitable for further consideration, to rigorous and rapid peer review by independent, anonymous expert referees. All peer review is double anonymized. Publishing Ethics Statement The Journal adheres to the highest standards of publishing ethics, with rigorous processes in place to ensure this is achieved. Taylor & Francis is a member of Committee of Publication Ethics (COPE) and utilizes Similarity Check via CrossRef for all journals. More information on our ethical standards and policies can be found here: http://authorservices.taylorandfrancis.com/ethics-for-authors/. The Journal has an appeals and complaints policy which can be viewed here: https://authorservices.taylorandfrancis.com/peer-review-appeals-and-complaints-from-authors/.
Journal metrics
Usage
32K annual downloads/views
Citation metrics
3.5 (2023) CiteScore (Scopus)
Q2 CiteScore Best Quartile
0.476 (2023) SNIP
0.354 (2023) SJR
Speed/acceptance
31 days avg. from submission to first
decision
55 days avg. from submission to first
post-review decision
10 days avg. from acceptance to online
publication
39% acceptance rate
Understanding and using journal metrics
Journal metrics can be a useful tool for readers, as well as for authors
who are deciding where to submit their next manuscript for publication.
However, any one metric only tells a part of the story of a journal’s
quality and impact. Each metric has its limitations which means that it
should never be considered in isolation, and metrics should be used to
support and not replace qualitative review.
We strongly recommend that you always use a number of metrics, alongside
other qualitative factors such as a journal’s aims & scope, its
readership, and a review of past content published in the journal. In
addition, a single article should always be assessed on its own merits and
never based on the metrics of the journal it was published in.
Usage and acceptance rate data above are for the last full calendar year
and are updated annually in February. Speed data is updated every six
months, based on the prior six months. Citation metrics are updated
annually mid-year. Please note that some journals do not display all of
the following metrics
(find out why).
Usage:
the total number of times articles in the journal were viewed by users
of Taylor & Francis Online in the previous calendar year, rounded to the
nearest thousand.
Citation Metrics
Impact Factor*:
the average number of citations received by articles published in the
journal within a two-year window. Only journals in the Clarivate Science
Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI),
Arts and Humanities Citation Index (AHCI) and the Emerging Sources
Citation Index (ESCI) have an Impact Factor.
Impact Factor Best Quartile*:
the journal’s highest subject category ranking in the Journal Citation
Reports. Q1 = 25% of journals with the highest Impact Factors.
5 Year Impact Factor*:
the average number of citations received by articles in the journal
within a five-year window.
CiteScore (Scopus)†:
the average number of citations received by articles in the journal over
a four-year period.
CiteScore Best Quartile†:
the journal’s highest CiteScore ranking in a Scopus subject category. Q1
= 25% of journals with the highest CiteScores.
SNIP
(Source Normalized Impact per Paper):
the number of citations per paper in the journal, divided by citation
potential in the field.
SJR
(Scimago Journal Rank):
Average number of (weighted) citations in one year, divided by the
number of articles published in the journal in the previous three years.
Speed/acceptance
From submission to first decision:
the average (median) number of days for a manuscript submitted to the
journal to receive a first decision. Based on manuscripts receiving a
first decision in the last six months.
From submission to first post-review decision:
the average (median) number of days for a manuscript submitted to the
journal to receive a first decision if it is sent out for peer review.
Based on manuscripts receiving a post-review first decision in the last
six months.
From acceptance to online publication:
the average (median) number of days from acceptance of a manuscript to
online publication of the Version of Record. Based on articles published
in the last six months.
Acceptance rate:
articles accepted for publication by the journal in the previous
calendar year as percentage of all papers receiving a final decision.
Editor-in-Chief Dr. Miriam Moscovitch- Lopatin Previously at Harvard Medical School and Massachusetts General Hospital (retired) Boston, MA, USA
Associate Editors Dr. Kyriakos Chatzopoulos Department of General and Anatomic Pathology Aristotle University of Thessaloniki Thessaloniki, Greece
Dr. Cristina Diaz Gallo Almirall, Barcelona, Spain
Founding Editor Dr. Jack Cazes
Editorial Board H.Y. Aboul-Enein - King Faisal Specialist Hospital & Research Centre, Riyadh, Saudi Arabia H. Ahsan - Faculty of Dentistry, Jamia Millia Islamia (A Central University), New Delhi, India R. Albulescu - National Institute for Chemical-Pharmaceutical R&D, Bucharest, Romania A. Bensussan - Hospital St. Louis, Cedex, France T.-D. Brumeanu - Herbert School of Medicine Uniformed Services University, Bethesda, MD, USA A. Chougule - PerkinElmer, Inc, Waltham, Massachusetts, USA F. Di Nardo -Forensic, Analytical & Bioanalytical Laboratories, University of Torino, Torino, Italy M. Dysinger -Alexion Pharmaceuticals, Inc., New Haven, CT, USA A. B. Engin - Gazi University, Faculty of Pharmacy, Department of Toxicology, Turkey R.G. Hamilton - Johns Hopkins A&A Center, Baltimore, MD, USA G. Kontogeorgos - G. Gennimatas Athens General Hospital, Department of Pathology, Greece P. Leblanc - Harvard Medical School, McLean Hospital, Belmont, MA, USA C. Leifer - College of Veterinary Medicine, Cornell University, Ithaca, NY, USA Y. A. Leong -University of California, San Francisco (UCSF), CA, USA; Monash University, Australia A. Leontovich - Mayo Clinic, Rochester, MN, USA Z. Lu - Molecular Diagnosis & Cell Therapy Department, Doing Institute of Translational Medicine, Beijing Doing Biomedical Technology Co., Ltd, Doing Medical Group, Beijing, P.R. China D. Lubman - University of Michigan, Ann Arbor, MI, USA C. Omatola -Kogi State University, Anyigba, Nigeria K. D. Pavelko - Immune Monitoring Core, Mayo Clinic College of Medicine and Science, Rochester, MN, USA A.Ravindran - Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA M. Shukla - Centers for Disease Control and Prevention, Atlanta, USA C. Staley - Immunology and Cancer Biology, University Minnesota, MN, USA C. Tanase - Victor Babes National Institute of Pathology, Bucharest, Romania; Titu Maiorescu University, Faculty of Medicine, Bucharest, Romania G. Tousinas - Mayo Clinic, Phoenix, AZ, USA X. Zhong - Duke University, Durham, NC, USA
Abstracting and indexing
Journal of Immunoassay and Immunochemistry is abstracted/indexed in:
• Adis International Ltd. Reactions Weekly • AIDS & Cancer Research • Chemical Abstracts Service Chemical Abstracts Online • EBSCOhost (various) • Elsevier BV BIOBASE EMBASE Scopus • Genamics JournalSeek • International Atomic Energy Agency INIS Collection Search • National Library of Medicine PubMed • OCLC ArticleFirst Electronic Collections Online • ProQuest (various) • Royal Society of Chemistry Analytical Abstracts • U.S. National Library of Medicine MEDLINE
Open access
Journal of Immunoassay and Immunochemistry is a hybrid open access journal that is part of our Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.
Why choose open access?
Increase the discoverability and readership of your article
Make an impact and reach new readers, not just those with easy access to a research library
Freely share your work with anyone, anywhere
Comply with funding mandates and meet the requirements of your institution, employer or funder
Rigorous peer review for every open access article
Article Publishing Charges (APC)
If you choose to publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis.
Journal of Immunoassay and Immunochemistry
(2001 - current)
Formerly known as
Journal of Immunoassay
(1980 - 2000)
Advertising information
Would you like to advertise in Journal of Immunoassay and Immunochemistry?
Reach an engaged target audience and position your brand alongside authoritative peer-reviewed research by advertising in Journal of Immunoassay and Immunochemistry.
Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors, make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .
Ready to submit?
Start a new submission or continue a submission in progress
![Sample our Physical Sciences journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/110820/Subject-Sample-2021-Physical-Sciences.jpg"})